Flu vaccine strains endorsed by FDA panel for 2013-2014

03/8/2013 | Medscape (free registration)

The FDA's Vaccines and Related Biological Products Advisory Committee endorsed a slightly different influenza vaccine composition for the 2013-2014 flu season, compared with that of the previous season. The committee recommended substituting two vaccine strains while retaining the A/California/7/2009pdm09-like virus. The committee also released recommendations for quadrivalent vaccines, noting that "global influenza virus surveillance data related to epidemiology and antigenic characteristics, serological responses to 2012-2013 seasonal vaccines, and the availability of candidate strains and reagents" were used as the basis for the recommendations.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA